Skip to main content
OpenTrials
Completed

NCT Number: NCT00562393

Effects of Excess Energy Intake on Metabolic Risk

The prevalence of obesity has reached epidemic proportions and is associated with the development of insulin resistance and type 2 diabetes (T2DM). A unifying theme has emerged over the past few years suggesting that lipid oversupply to metabolic organs responsible for glucose regulation leads to insulin resistance. Fitting with this, we and others have shown that increased lipid accumulation within skeletal muscle and/or liver is associated with impaired glucose uptake. However, the underlying mechanisms that mediate changes in muscle lipid metabolism are not yet known. The overall aim of this project is to examine metabolic effects of experimental weight gain in lean and overweight individuals with and without a genetic predisposition to type 2 diabetes. We hypothesise that lean subjects will increase fatty acid oxidation and upregulate mitochondrial oxidative capacity in muscle following overfeeding to protect against body weight gain and insulin resistance, but overweight subjects with a genetic predisposition to T2DM will have a defect in this ability.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Garvan Institute of Medical Research

Darlinghurst, New South Wales, 2010, Australia

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Sedentary (<60 min formal exercise per week)
  • Aged 20-65 years

Exclusion criteria

  • Personal history of diabetes, cardiovascular disease or hypertension
  • Recent weight change (larger than 4kg in the past 3 months)
  • Smoking
  • Regular use of medications, except oral contraceptives
  • Individuals with alcoholism or other substance abuse
  • Pregnancy or lactation, women who are planning to become pregnant or who are not using adequate measures of birth control.

Treatment and study plan

nutritional

Other

Overfeeding high fat diet for 28 days

Primary outcomes

  1. Insulin sensitiviy by hyperinsulinemic clamp

    Time frame: 28-days

Secondary outcomes

  1. Fat oxidation (whole body RQ and C-14 palmitate), mitochondrial function

    Time frame: 28-days

Sponsors and collaborators

Lead sponsor

Garvan Institute of Medical Research

Other

Registry information

Acronym: EXCESS

Important dates

Study start
2007
Primary completion
2009
Study completion
2009
First posted
Nov 22, 2007
Registry last updated
Jul 14, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.